falseQ3Austerlitz Acquisition Corp I0001838207--12-31true 0001838207 2022-09-30 0001838207 2021-12-31 0001838207 2022-07-01 2022-09-30 0001838207 2021-07-01 2021-09-30 0001838207 2022-01-01 2022-09-30 0001838207 2021-01-01 2021-09-30 0001838207 2021-01-01 2021-03-31 0001838207 2021-03-02 0001838207 2022-01-01 2022-03-31 0001838207 2022-04-01 2022-06-30 0001838207 2021-04-01 2021-06-30 0001838207 2020-12-31 0001838207 2021-09-30 0001838207 2022-03-31 0001838207 2022-06-30 0001838207 2021-03-31 0001838207 2021-06-30 0001838207 us-gaap:CommonClassAMember 2022-09-30 0001838207 us-gaap:CommonClassBMember 2022-09-30 0001838207 us-gaap:CommonClassCMember 2022-09-30 0001838207 us-gaap:PrivatePlacementMember 2022-09-30 0001838207 ausu:PrivatePlacementWarrantsMember ausu:SponsorMember 2022-09-30 0001838207 srt:MinimumMember ausu:BusinessCombinationsMember 2022-09-30 0001838207 ausu:SharePriceMoreThanOrEqualsToUsdTwelveMember ausu:FounderSharesMember 2022-09-30 0001838207 ausu:SponsorMember ausu:RelatedPartyLoanMember 2022-09-30 0001838207 ausu:PrivatePlacementWarrantsMember 2022-09-30 0001838207 ausu:PublicWarrantsMember 2022-09-30 0001838207 ausu:PublicWarrantsMember us-gaap:CommonClassAMember ausu:TriggerPriceOneMember 2022-09-30 0001838207 ausu:PublicWarrantsMember us-gaap:CommonClassAMember ausu:TriggerPriceTwoMember 2022-09-30 0001838207 srt:MinimumMember ausu:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember 2022-09-30 0001838207 srt:MaximumMember ausu:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember 2022-09-30 0001838207 ausu:PublicWarrantsMember ausu:TriggerPriceOneMember 2022-09-30 0001838207 ausu:TriggerPriceOneMember 2022-09-30 0001838207 ausu:PublicWarrantsMember ausu:TriggerPriceTwoMember 2022-09-30 0001838207 us-gaap:CommonClassCMember ausu:ThirdAnniversaryMember 2022-09-30 0001838207 us-gaap:CommonClassCMember ausu:SixthAnniversaryMember 2022-09-30 0001838207 ausu:NinthAnniversaryMember us-gaap:CommonClassCMember 2022-09-30 0001838207 ausu:WorkingCapitalLoanMember 2022-09-30 0001838207 ausu:ClassASubjectToRedemptionMember 2022-09-30 0001838207 ausu:AdministrativeServicesAgreementMember ausu:CannaeHoldingsIncMember 2022-09-30 0001838207 ausu:SponsorMember ausu:OperatingCostsMember 2022-09-30 0001838207 us-gaap:CommonClassAMember 2021-12-31 0001838207 us-gaap:CommonClassBMember 2021-12-31 0001838207 us-gaap:CommonClassCMember 2021-12-31 0001838207 ausu:WorkingCapitalLoanMember 2021-12-31 0001838207 ausu:PublicWarrantsMember 2021-12-31 0001838207 ausu:PrivatePlacementWarrantsMember 2021-12-31 0001838207 ausu:CannaeHoldingsIncMember ausu:AdministrativeServicesAgreementMember 2021-12-31 0001838207 ausu:SponsorMember ausu:OperatingCostsMember 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member ausu:PublicWarrantsMember 2021-12-31 0001838207 ausu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001838207 ausu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember ausu:PublicWarrantsMember 2021-12-31 0001838207 ausu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member ausu:PrivatePlacementWarrantsMember 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member ausu:PrivatePlacementWarrantsMember 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember ausu:PrivatePlacementWarrantsMember 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001838207 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001838207 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001838207 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001838207 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001838207 us-gaap:CommonClassCMember 2022-07-01 2022-09-30 0001838207 ausu:ClassARedeemableCommonStockMember 2022-07-01 2022-09-30 0001838207 ausu:ClassaRedeemableOrdinarySharesMember 2022-07-01 2022-09-30 0001838207 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001838207 us-gaap:CommonClassAMember 2021-07-01 2021-09-30 0001838207 us-gaap:CommonClassBMember 2021-07-01 2021-09-30 0001838207 us-gaap:CommonClassCMember 2021-07-01 2021-09-30 0001838207 ausu:ClassARedeemableCommonStockMember 2021-07-01 2021-09-30 0001838207 ausu:ClassaRedeemableOrdinarySharesMember 2021-07-01 2021-09-30 0001838207 us-gaap:PrivatePlacementMember 2022-01-01 2022-09-30 0001838207 us-gaap:IPOMember 2022-01-01 2022-09-30 0001838207 ausu:PrivatePlacementWarrantsMember ausu:SponsorMember 2022-01-01 2022-09-30 0001838207 srt:MinimumMember 2022-01-01 2022-09-30 0001838207 srt:MaximumMember 2022-01-01 2022-09-30 0001838207 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001838207 ausu:SponsorMember ausu:RelatedPartyLoanMember 2022-01-01 2022-09-30 0001838207 ausu:WorkingCapitalLoanMember 2022-01-01 2022-09-30 0001838207 ausu:PublicWarrantsMember 2022-01-01 2022-09-30 0001838207 ausu:PublicWarrantsMember us-gaap:CommonClassAMember ausu:TriggerPriceOneMember 2022-01-01 2022-09-30 0001838207 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001838207 us-gaap:CommonClassCMember 2022-01-01 2022-09-30 0001838207 ausu:SponsorMember 2022-01-01 2022-09-30 0001838207 ausu:AdministrativeServicesAgreementMember 2022-01-01 2022-09-30 0001838207 ausu:PrivatePlacementWarrantsMember 2022-01-01 2022-09-30 0001838207 ausu:ClassASubjectToRedemptionMember us-gaap:IPOMember 2022-01-01 2022-09-30 0001838207 ausu:ClassASubjectToRedemptionMember 2022-01-01 2022-09-30 0001838207 ausu:ConversionOfClassBToClassACommonStockInCompletionOfBusinessCombinationMember 2022-01-01 2022-09-30 0001838207 ausu:UnitsMember 2022-01-01 2022-09-30 0001838207 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001838207 ausu:ClassARedeemableCommonStockMember 2022-01-01 2022-09-30 0001838207 ausu:ClassaRedeemableOrdinarySharesMember 2022-01-01 2022-09-30 0001838207 ausu:AdministrativeServicesAgreementMember 2021-01-01 2021-09-30 0001838207 us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001838207 us-gaap:CommonClassBMember 2021-01-01 2021-09-30 0001838207 us-gaap:CommonClassCMember 2021-01-01 2021-09-30 0001838207 ausu:ClassARedeemableCommonStockMember 2021-01-01 2021-09-30 0001838207 ausu:ClassaRedeemableOrdinarySharesMember 2021-01-01 2021-09-30 0001838207 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001838207 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001838207 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassCMember 2021-01-01 2021-03-31 0001838207 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001838207 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001838207 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001838207 us-gaap:OverAllotmentOptionMember 2021-03-02 2021-03-02 0001838207 us-gaap:IPOMember 2021-03-02 2021-03-02 0001838207 us-gaap:IPOMember 2021-03-02 0001838207 ausu:SponsorMember 2021-01-04 2021-01-04 0001838207 ausu:SponsorMember us-gaap:CommonClassBMember 2021-01-04 2021-01-04 0001838207 ausu:SponsorMember us-gaap:CommonClassCMember 2021-01-04 2021-01-04 0001838207 ausu:SponsorMember us-gaap:CommonClassBMember 2021-02-25 2021-02-25 0001838207 ausu:SponsorMember us-gaap:CommonClassCMember 2021-02-25 2021-02-25 0001838207 ausu:SponsorMember us-gaap:CommonClassBMember 2021-02-25 0001838207 ausu:SponsorMember us-gaap:CommonClassCMember 2021-02-25 0001838207 us-gaap:SubsequentEventMember 2022-10-03 0001838207 ausu:SponsorMember 2021-01-01 2021-12-31 0001838207 us-gaap:CommonClassAMember 2022-11-04 0001838207 us-gaap:CommonClassBMember 2022-11-04 0001838207 us-gaap:CommonClassCMember 2022-11-04 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-09-30 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassCMember 2022-09-30 0001838207 us-gaap:RetainedEarningsMember 2022-09-30 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-09-30 0001838207 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2021-09-30 0001838207 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001838207 us-gaap:RetainedEarningsMember 2021-09-30 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassCMember 2021-12-31 0001838207 us-gaap:RetainedEarningsMember 2021-12-31 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-03-31 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassCMember 2022-03-31 0001838207 us-gaap:RetainedEarningsMember 2022-03-31 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-06-30 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassCMember 2022-06-30 0001838207 us-gaap:RetainedEarningsMember 2022-06-30 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-12-31 0001838207 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2020-12-31 0001838207 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001838207 us-gaap:RetainedEarningsMember 2020-12-31 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 0001838207 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2021-03-31 0001838207 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001838207 us-gaap:RetainedEarningsMember 2021-03-31 0001838207 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-06-30 0001838207 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2021-06-30 0001838207 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001838207 us-gaap:RetainedEarningsMember 2021-06-30 iso4217:USD xbrli:shares xbrli:pure utr:Year utr:Day iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM

10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number

001-40110

AUSTERLITZ ACQUISITION CORPORATION I

(Exact name of registrant as specified in its charter)


Cayman Islands		98-1583472
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification Number)

1701 Village Center Circle,
Las Vegas, Nevada		89134
(Address of principal executive offices)		(Zip Code)

(702)

323-7330

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class	Trading Symbols	Name of Each Exchange on Which Registered
Units, each consisting of one Class A Ordinary Share and one-fourth of one Warrant	AUS.U	New York Stock Exchange
Class A Ordinary Shares, par value $0.0001 per share	AUS	New York Stock Exchange
Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (1)		None

(1) A Form 25 was filed with the Securities and Exchange Commission (“SEC”) on October 19, 2022 to delist and deregister these Warrants. The delisting of the

Warrants was

effective 10 days after the filing of the Form 25. The deregistration of the Warrants under Section 12(b) of the Securities Exchange Act of 1934 will be effective 90 days, or such shorter period as the SEC may determine, after the filing of the Form 25.

he Warrants are no longer trading on the New York Stock Exchange.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). YES ☒ NO ☐

As of

November 4

, 2022, there were 69,000,000 shares of Class A ordinary shares, 14,785,715 shares of Class B ordinary shares and 14,785,715 shares of Class C ordinary shares of the Registrant issued and outstanding.

AUSTERLITZ ACQUISITION CORPORATION I

FORM 10-Q FOR THE QUARTER ENDED

SEPTEMBER 30, 2022

TABLE OF CONTENTS


		Page
PART I – FINANCIAL INFORMATION			3

Item 1.	Financial Statements		3

	Condensed Consolidated Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021		3

	Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2022 and 2021		4

	Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2022 and 2021		5

	Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021		6

	Notes to Unaudited Condensed Consolidated Financial Statements		7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		19

Item 4.	Control and Procedures		22

PART II – OTHER INFORMATION			23

Item 1A.	Risk Factors		23

Item 6.	Exhibits		23

SIGNATURES			24

PART I—FINANCIAL INFORMATION

Item 1.

Financial Statements

AUSTERLITZ ACQUISITION CORPORATION I

CONDENSED CONSOLIDATED BALANCE SHEETS


	September 30, 2022 (Unaudited)			December 31, 2021
ASSETS
Cash	$	1,502,331		$	3,968,177
Prepaid expenses		173,955			379,400
Other current assets		—			15,524

Total current assets		1,676,286			4,363,101
Cash held in Trust Account		690,000,000			690,000,000
Other non-current assets		—			55,717

Total Assets	$	691,676,286		$	694,418,818

LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	28,184		$	12,555
Due to related party		32,116			82,116
Accrued offering costs		442,516			442,516
Accrued expenses		89,058			2,019,500

Total current liabilities		591,874			2,556,687
Deferred underwriting fees payable		24,150,000			24,150,000
Derivative warrant liabilities		—			29,172,500

Total liabilities		24,741,874			55,879,187

Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption, 69,000,000 shares at $10.00 redemption value		690,000,000			690,000,000
Shareholders’ deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—			—
Class A ordinary shares, $0.0001 par value; 800,000,000 shares authorized; none issued and outstanding (excluding 69,000,000 shares subject to possible redemption)		—			—
Class B ordinary shares, $0.0001 par value; 80,000,000 shares authorized; 14,785,715 shares issued and outstanding at September 30, 2022 and December 31, 2021		1,479			1,479
Class C ordinary shares, $0.0001 par value; 80,000,000 shares authorized; 14,785,715 shares issued and outstanding at September 30, 2022 and December 31, 2021		1,479			1,479
Additional paid-in capital		—			—
Accumulated deficit		(23,068,546	)		(51,463,327	)

Total shareholders’ deficit		(23,065,588	)		(51,460,369	)

Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit	$	691,676,286		$	694,418,818

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	Three Months Ended September 30, 2022			Three Months Ended September 30, 2021			Nine Months Ended September 30, 2022			Nine Months Ended September 30, 2021
General and administrative expenses	$	256,251		$	2,326,673		$	777,719		$	3,079,072

Loss from operations		(256,251	)		(2,326,673	)		(777,719	)		(3,079,072	)

Other income (expense):
Transaction costs allocated to derivative warrant liabilities		—			—			—			(1,605,246	)
Change in fair value of derivative warrant liabilities		7,634,860			1,111,334			29,172,500			(3,677,499	)
Change in fair value of backstop liability		—			5,251,008			—			2,212,251
Backstop placement fee expense		—			—			—			(3,450,000	)

Net income (loss)	$	7,378,609		$	4,035,669		$	28,394,781		$	(9,599,566	)

Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted		69,000,000			69,000,000			69,000,000			53,835,165

Basic and diluted net income (loss) per share, Class A ordinary shares subject to possible redemption	$	0.07		$	0.04		$	0.29		$	(0.12	)

Weighted average shares outstanding of Class B ordinary shares, basic and diluted		14,785,715			14,785,715			14,785,715			14,785,715

Basic and diluted net income (loss) per share, Class B ordinary shares	$	0.07		$	0.04		$	0.29		$	(0.12	)

Weighted average shares outstanding of Class C ordinary shares, basic and diluted		14,785,715			14,785,715			14,785,715			14,785,715

Basic and diluted net income (loss) per share, Class C ordinary shares	$	0.07		$	0.04		$	0.29		$	(0.12	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

(Unaudited)


	Ordinary Shares
	Class B				Class C
	Shares		Amount		Shares		Amount		Additional Paid-In Capital		Accumulated Deficit			Total Shareholders’ Deficit
Balance as of January 1, 2022		14,785,715	$	1,479		14,785,715	$	1,479	$	—	$	(51,463,327	)	$	(51,460,369	)
Net income		—		—		—		—		—		13,640,084			13,640,084

Balance as of March 31, 2022		14,785,715	$	1,479		14,785,715	$	1,479	$	—	$	(37,823,243	)	$	(37,820,285	)
Net income		—		—		—		—		—		7,376,088			7,376,088

Balance as of June 30, 2022		14,785,715	$	1,479		14,785,715	$	1,479	$	—	$	(30,447,155	)	$	(30,444,197	)
Net income		—		—		—		—		—		7,378,609			7,378,609

Balance as of September 30, 2022		14,785,715	$	1,479		14,785,715	$	1,479	$	—	$	(23,068,546	)	$	(23,065,588	)


	Ordinary Shares
	Class B				Class C
	Shares		Amount		Shares		Amount		Additional Paid-In Capital			Accumulated Deficit			Total Shareholders’ Deficit
Balance as of January 1, 2021		—	$	—		—	$	—	$	—		$	(5,000	)	$	(5,000	)
Issuance of Class B and Class C ordinary shares to Sponsor		14,785,715		1,479		14,785,715		1,479		22,042			—			25,000
Cancellation of Class B ordinary share to Sponsor		—		—		—		—		—			—			—
Adjustment of Class A ordinary shares to redemption value		—		—		—		—		(22,042	)		(65,736,507	)		(65,758,549	)
Net loss		—		—		—		—		—			(5,752,119	)		(5,752,119	)

Balance as of March 31, 2021		14,785,715	$	1,479		14,785,715	$	1,479	$	—		$	(71,493,626	)	$	(71,490,668	)
Net loss		—		—		—		—		—			(7,883,116	)		(7,883,116	)

Balance as of June 30, 2021		14,785,715	$	1,479		14,785,715	$	1,479	$	—		$	(79,376,742	)	$	(79,373,784	)
Net income		—		—		—		—		—			4,035,669			4,035,669

Balance as of September 30, 2021		14,785,715	$	1,479		14,785,715	$	1,479	$	—		$	(75,341,073	)	$	(75,338,115	)

The accompany notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	For The Nine Months Ended September 30, 2022			For The Nine Months Ended September 30, 2021
Cash Flows from Operating Activities
Net income (loss)	$	28,394,781		$	(9,599,566	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
(Gain) loss on change in fair value of warrant liability		(29,172,500	)		3,677,499
Gain on change in fair value of backstop liability		—			(2,212,251	)
Offering cost allocated to warrant liability		—			1,605,246
Backstop placement fee payable to related party		—			3,450,000
Changes in operating assets and liabilities:
Prepaid expenses		205,445			(363,153	)
Other assets		71,241			18,894
Accounts payable		15,629			19,243
Accrued expenses		(1,930,442	)		2,341,895
Due to related party		(50,000	)		17,450

Net cash used in operating activities		(2,465,846	)		(1,044,743	)

Cash Flows from Investing Activities
Investment of cash into Trust Account		—			(690,000,000	)

Net cash used in investing activities		—			(690,000,000	)

Cash Flows from Financing Activities
Advances from related party		—			166,827
Repayment of promissory note—related party		—			(191,827	)
Proceeds from sale of Units, net of offering costs		—			675,446,205
Proceeds from sale of Private Placement Warrants		—			15,800,000

Net cash provided by financing activities		—			691,221,205

Net (decrease) increase in cash		(2,465,846	)		176,462
Cash—beginning of period		3,968,177			—

Cash—end of period	$	1,502,331		$	176,462

Supplemental disclosure of noncash investing and financing activities:
Issuance of Class B and Class C ordinary shares to Sponsor as settlement of due to related party		—			25,000
Deferred offering costs included in accrued expenses		—			442,516
Offering costs paid through promissory note – related party		—			186,827
Deferred underwriting fees payable		—			24,150,000

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Austerlitz Acquisition Corporation I (the “Company”) was incorporated as a Cayman Islands exempted company on December 21, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”).

As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022, related to the Company’s formation and the initial public offering and efforts to identify and complete a business combination, which is described below.

On March 2, 2021, the Company consummated its initial public offering (the “IPO” or “Initial Public Offering”) of 69,000,000 units (the “Units”), including 9,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover over-allotments. The Units, each consisting of one Class A ordinary share (the “Public Shares”) and

one-fourth

of a redeemable warrant (each whole warrant a “Public Warrant”), were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $690,000,000, which is described in Note 3.

Simultaneously with the closing of the IPO, the Company completed a private sale of an aggregate 10,533,333 warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) at a purchase price of $1.50 per Private Placement Warrant (the “Private Placement”) to Austerlitz Acquisition Sponsor, LP I, (the “Sponsor”) generating aggregate gross proceeds to the Company of $15,800,000, which is described in Note 4.

Offering costs consist of legal, accounting and other costs incurred through the balance sheet date that are directly related to the IPO and were primarily charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the IPO in March 2021. Offering costs of $1,605,246 were allocated to warrant liabilities and expensed as incurred.

Following the closing of the IPO and Private Placement on March 2, 2021, an amount of $690,000,000 ($10.00 per Unit) of the net proceeds were placed in a U.S.-based trust account (“Trust Account”). Except with respect to interest earned, if any, the proceeds from the IPO and the Private Placements held in the trust account will not be released until the earliest of (a) the completion of a Business Combination, (b) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of its obligation to redeem 100% of its public shares if the Company does not complete its initial Business Combination within 24 months from the closing of the IPO or (ii) with respect to any other provisions relating to shareholders’ rights or

pre-initial

Business Combination activity, and (c) the redemption of all of the Public Shares (as defined in Note 4) if it is unable to complete its Business Combination within 24 months from the closing of the IPO, subject to applicable law.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with an initial business combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act.

The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s Warrants. The Class A ordinary shares are recorded at redemption value and classified as temporary equity, in accordance with ASC 480.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

If the Company seeks shareholder approval in connection with a Business Combination, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who vote at a general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association (“Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), Alignment Shares (as defined in Note 5) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination and not to convert any shares in connection with a shareholder vote to approve a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.

The Company has until March 2, 2023, which is 24 months from the closing of the IPO (the “Combination Period”), to consummate a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned, if such funds are held in an interest-bearing account (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors (the “Board”), liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

On October 3, 2022, the Company filed a preliminary proxy statement to redeem the Public Shares through a tender offer and amend its March 2, 2023 expiration date to the chosen date of the shareholder meeting for which proxies are being solicited. Upon approval by the Company’s shareholders of the proposals set forth in the proxy statement, the Company would redeem the Public Shares and begin liquidation proceedings. The Company plans to return the cash held in the Trust Account to holders of Public Shares within calendar year 2022. There have been no reductions to the amount of funds in the Trust Account and the Company expects to return approximately $10.00 per Public Share to shareholders upon redemption of its Public Shares.

Liquidity and Going Concern Consideration

As of September 30, 2022 and December 31, 2021, the Company had $1,502,331 and $3,968,177 in cash, respectively, and net working capital of $1,804,412 and $1,806,414, respectively.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

The Company’s liquidity needs through September 30, 2022 and December 31, 2021, were satisfied through a contribution of $

25,000

from the Sponsor to cover certain expenses in exchange for the issuance of the Founder and Alignment Shares, loans from the Sponsor, the termination fee received pursuant to the Mutual Termination Agreement and the proceeds from the consummation of the IPO and Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (defined below, see Note 5). As of September 30, 2022, there were no amounts outstanding under the Working Capital Loans.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”)

2014-15,

“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company considered that it has until March 2, 2023 to consummate a business combination. On October 3, 2022, the Company filed a preliminary proxy statement to redeem the Public Shares through a tender offer and amend its March 2, 2023 expiration date to the chosen date of the shareholder meeting for which proxies are being solicited. Upon approval by the Company’s shareholders of the proposals set forth in the proxy statement, the Company would redeem the Public Shares and begin liquidation proceedings. The Sponsor believes that consummation of a suitable business combination is highly improbable, and it is therefore in shareholders’ best interests to return the cash held in the Trust Account to holders of Public Shares within calendar 2022 rather than wait for expiration in 2023. The Company will be dissolved subsequent to the return of the cash in trust to holders of Public Shares. Management has determined that the liquidity condition and mandatory liquidation and subsequent dissolution raise substantial doubt about the ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities for liquidation.

The Company expects to complete the redemption of our outstanding Class A ordinary shares (the “Public Shares”) in exchange for the cash held in the Trust Account prior to December 31, 2022.

Risks and Uncertainties

Management continues to evaluate the impact of the

COVID-19

pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and the closing of the Business Combination, the specific impact is not readily determinable as of the date of the condensed consolidated financial statements. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. This report should be read in conjunction with our Annual Report on Form 10-K (our “Annual Report”) for the year ended December 31, 2021.

The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or any future period.

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statement, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available; and, accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 or December 31, 2021.

Offering costs

Offering costs consisted of legal, accounting, and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.

Warrant Liabilities

The Company accounts for the Warrants as either an equity-classified or liability-classified instrument based on an assessment of the specific terms of the Warrants and the applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the Warrants are freestanding financial instruments pursuant to ASC 480, or meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815, including whether the Warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance of the Warrants and as of each subsequent quarterly period end date while the Warrants are outstanding. For issued or modified instruments such as warrants and forward purchases of equity that meet all of the criteria for equity classification, such instruments are required to be recorded as a component of additional

paid-in

capital at the time of issuance. For issued or modified instruments that do not meet all the criteria for equity classification, such instruments are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of liability-classified instruments are recognized as a

non-cash

gain or loss on the condensed consolidated statements of operations.

The Company accounts for the Warrants in accordance with ASC

815-40

under which the Warrants do not meet the criteria for equity classification and must be recorded as assets or liabilities. The Warrant liabilities are included in Warrant liability on the unaudited condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021. See Note 8 for further discussion of the pertinent terms of the Warrants and Note 9 for further discussion of the methodology used to determine the fair value of the Company’s liabilities for the Warrants.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Cash Held in Trust Account

As of September 30, 2022 and December 31, 2021, the assets held in the Trust Account were held in cash.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A Ordinary shares subject to mandatory redemption are classified as a liability and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2022 and December 31, 2021, 69,000,000 shares of Class A ordinary shares subject to possible redemption are presented at the current redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s unaudited condensed consolidated balance sheets.

As of September 30, 2022 and December 31, 2021, Class A ordinary shares reflected on the condensed consolidated balance sheets are reconciled in the following table:


Gross proceeds from sale of Class A ordinary shares	$	690,000,000
Less: Allocation to public warrants		(28,635,000	)
Less: Issuance costs attributable to Class A ordinary shares		(37,123,549	)
Adjustment of Class A ordinary shares to redemption value		65,758,549

Class A ordinary shares subject to possible redemption	$	690,000,000

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account at a financial institution which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

•

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

As of September 30, 2022 and December 31, 2021, the carrying values of cash, accrued expenses, deferred offering costs and due to related party approximate their fair values due to the short-term nature of the instruments. See Note 9 for further discussion of the fair value of the warrant liabilities.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Net Income (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of ASC Topic 260,

Earnings Per Share

. The Company has three classes of shares, one for each of its Class A, Class B, and Class C ordinary shares. Income and losses are shared pro rata between the three classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is computed by dividing net income or loss by the weighted average number of ordinary shares outstanding for the year. Net income (loss) is allocated to the Company’s Class A, B and C ordinary shares based on the relative shares outstanding for each class of shares compared to the Company’s total shares outstanding. The Company has not considered the effect of the Public Warrants or the Private Placement Warrants in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events.

The Company’s basic and diluted earnings (loss) per share are calculated as follows:


	For The Three Months Ended September 30, 2022 (Unaudited)		For The Three Months Ended September 30, 2021 (Unaudited)		For The Nine Months Ended September 30, 2022 (Unaudited)		For The Nine Months Ended September 30, 2021 (Unaudited)
Class A Ordinary Shares Subject to Possible Redemption
Net earnings (loss) allocable to Class A ordinary shares	$	5,165,027	$	2,824,968	$	19,876,347	$	(6,196,083	)
Basic and diluted weighted average shares outstanding, Class A ordinary shares		69,000,000		69,000,000		69,000,000		53,835,165

Basic and diluted net earnings (loss) per share, Class A ordinary shares subject to possible redemption	$	0.07	$	0.04	$	0.29	$	(0.12	)

Class B Ordinary Shares
Net earnings (loss) allocable to Class B ordinary shares	$	1,106,791	$	605,350	$	4,259,217	$	(1,701,741	)
Basic and diluted weighted average shares outstanding, Class B ordinary shares		14,785,715		14,785,715		14,785,715		14,785,715

Basic and diluted net earnings (loss) per share, Class B ordinary shares	$	0.07	$	0.04	$	0.29	$	(0.12	)

Class C Ordinary Shares
Net earnings (loss) allocable to Class C ordinary shares	$	1,106,791	$	605,350	$	4,259,217	$	(1,701,741	)
Basic and diluted weighted average shares outstanding, Class C ordinary shares		14,785,715		14,785,715		14,785,715		14,785,715

Basic and diluted net earnings (loss) per share, Class C ordinary shares	$	0.07	$	0.04	$	0.29	$	(0.12	)

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740,

Income Taxes

, which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be

more-likely-than-not

to be sustained upon examination by taxing authorities. The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Recent Accounting Pronouncements

In August 2020, the FASB issued Accounting Standards Update

No. 2020-06,

Debt—Debt with Conversion and Other Options

, which among other things adds certain specific requirements to achieve equity classification and/or qualify for the derivative scope exception for contracts indexed to an entity’s own equity, which is expected to result in more freestanding instruments and embedded features to qualify for equity accounting treatment. The new standard is effective for companies that are SEC filers (except for Smaller Reporting Companies) for fiscal years beginning after December 15, 2021 and interim periods within that year, and two years later for other companies. Companies can early adopt the standard at the start of a fiscal year beginning after December 15, 2020. The standard can either be adopted on a modified retrospective or a full retrospective basis. The Company has evaluated the newly issued standard and does not believe it will materially impact the Company.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the IPO, the Company sold 69,000,000 Units at a purchase price of $10.00 per Unit, including 9,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover over-allotments. Each Unit consists of one Public Share and

one-quarter

of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8).

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the IPO, the Company completed the Private Placement to the Sponsor generating aggregate gross proceeds to the Company of $ 15,800,000. Each Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Refer to Note 1 and Note 10 for discussion of the Company’s preliminary proxy statement and plan to return the cash held in the Trust Account to holders of Public Shares in calendar year 2022.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares and Alignment Shares

On January 4, 2021, the Sponsor paid an aggregate of $25,000 in exchange for the issuance of 12,321,429 shares of Class B ordinary shares (the “Founder Shares”) and 12,321,429 shares of Class C ordinary shares (the “Alignment Shares”). On February 25, 2021, the Sponsor received a share dividend of 2,464,286 Founder Shares and 2,464,286 Alignment Shares, resulting in there being an aggregate of 14,785,715 Founder Shares and 14,785,715 Alignment Shares outstanding. All share and per share amounts have been retroactively restated.

The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its (1) Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $ 12.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 150 days after the completion of a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, stock exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; and (2) Alignment Shares and any Class A ordinary shares issued upon conversion thereof until the earlier of: (A) their conversion into Class A ordinary shares; and (B) subsequent to a Business Combination, the date on which the Company completes a merger, share exchange, reorganization or other similar transaction that results in both a change in control and all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property.

The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares , Alignment Shares and any Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholder’s rights or

pre-initial

Business Combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Alignment Shares if the Company fails to consummate a Business Combination.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Alignment Shares if the Company fails to complete a Business Combination within the Combination Period. However, any Public Shares held by the Sponsor will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

As further described in Note 1 and 10, the Company plans to redeem its Public Shares for the cash held in the Trust Account in calendar year 2022. The Sponsor does not own any Public Shares and therefore will not receive any proceeds from the liquidation of the Trust Account.

Promissory Note – Related Parties

On January 5, 2021, the Company issued a promissory note (the “Promissory Note”) to the Sponsor and an affiliate of the Sponsor, pursuant to which the Company could borrow up to an aggregate principal amount of $800,000. The Promissory Note was

non-interest

bearing and payable on the earlier of (i) September 30, 2021, or (ii) the completion of the IPO. The outstanding balance under the Promissory Note of $191,827 was repaid upon consummation of the IPO.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into up to an additional 1,000,000 warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.

Administrative Services Agreement

Commencing on February 25, 2021, the Company agreed to pay an affiliate of its Sponsor a total of $5,000 per month for office space, utilities, and secretarial and administrative support services. For the nine months ended September 30, 2022 and 2021, the Company incurred and accrued $45,000 and $35,000, respectively, of administrative services under this arrangement. Upon completion of a Business Combination or the Company’s liquidation, the Company will no longer be obligated to pay these monthly fees. As of September 30, 2022, and December 31, 2021, $5,000 and $55,000, respectively, of administrative support services fees were unpaid and included in due to related party on the condensed consolidated balance sheets.

Due to related party

From time to time, an affiliate of the Sponsor pays certain operating costs on behalf of the Company. These advances are due on demand and

non-interest

bearing. As of September 30, 2022 and December 31, 2021, the amounts due to the related party were $32,116 and $82,116, respectively.

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the Founder Shares, Alignment Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares and Alignment Shares) are entitled to registration rights pursuant to a registration rights agreement (the “Registration Rights Agreement”) requiring the Company to register such securities for resale (in the case of the Founder Shares and Alignment Shares, only after conversion to the Company’s Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the Registration Rights Agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statement.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Underwriting Agreement

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $24,150,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. As further described in Note 1 and 10, the Company plans to redeem its Public Shares for the cash held in the Trust Account in calendar year 2022. We do not expect to complete a Business Combination and we do not expect for the deferred underwriting fee to become payable.

NOTE 7. SHAREHOLDERS’ DEFICIT

Preference Shares

The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. The Company’s Board is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Board is able to, without shareholder approval, issue preference shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. As of September 30, 2022 and December 31, 2021, there were no preference shares issued or outstanding.

Class A Ordinary Shares

The Company is authorized to issue 800,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were no Class A ordinary shares issued and outstanding, excluding 69,000,000 Class A ordinary shares subject to possible redemption and classified in temporary equity at September 30, 2022 and December 31, 2021.

Class B Ordinary Shares

The Company is authorized to issue 80,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 14,785,715 Class B ordinary shares issued and outstanding.

The Class B ordinary shares will automatically convert into Class A ordinary shares on the business day following the completion of a Business Combination, on a

one-for-one

basis, subject to adjustment.

Class C Ordinary Shares

The Company is authorized to issue 80,000,000 Class C ordinary shares with a par value of $0.0001 per share. Holders of the Class C ordinary shares are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 14,785,715 Class C ordinary shares issued and outstanding.

The Class C ordinary shares will automatically convert into Class A ordinary shares at the earlier of (i) a time after the completion of a Business Combination in which the last reported sale price of Class A ordinary shares for any 20 trading days within a

30-trading

day period equals or exceeds $15.25 if occurring before the third anniversary of a Business Combination, $23.00 if occurring before the sixth anniversary of a Business Combination or $35.00 if occurring before the ninth anniversary of a Business Combination, and (ii) subsequent to the completion of a Business Combination, the date on which the Company completes a merger, share exchange, reorganization or other similar transaction that results in both a change of control and all of its public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property, in each case, on a

one-for-one

basis, subject to adjustment. The Class C ordinary shares will be returned to the Company for cancellation in the event that they have not converted into Class A ordinary shares nine years after a Business Combination.

In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the IPO and related to the closing of the Company’s initial Business Combination, except if such is the result of the conversion of the Company’s Class B ordinary shares or Class C ordinary shares, the ratio at which the Class B ordinary shares and Class C ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

outstanding Class B ordinary shares and Class C ordinary shares, as applicable in each case, agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares and Class C ordinary shares will equal, in the aggregate, on an

as-converted

basis, 15% and 15%, respectively, of the sum of (i) the total number of the Company’s issued and outstanding ordinary shares upon completion of the IPO, plus (ii) the total number of ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or deemed issued by the Company in connection with or in relation to the completion of the initial Business Combination (including the forward purchase shares, but not the forward purchase warrants), excluding (1) any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination, and (2) any private placement warrants issued to the Sponsor or any of its affiliates upon conversion of working capital loans. Any conversion of Class B ordinary shares or Class C ordinary shares described herein will take effect as a compulsory redemption of Class B ordinary shares or Class C ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. In no event will Class B ordinary shares or Class C ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

NOTE 8. WARRANTS

As of September 30, 2022 and December 31, 2021, there were 17,250,000 Public Warrants outstanding. Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of a Business Combination, provided that an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or we permit holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of the Company’s Class A ordinary shares. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the units, no cash will be paid in lieu of fractional warrants and only whole warrants will trade.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the Warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied the excess of the “fair market value” less the exercise price of the warrants by (y) the fair market value and (B) 0.3611 Class A ordinary shares per whole warrant. The “fair market value” shall mean the volume weighted average price of the Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.

Redemption of warrants when the price per Class

A ordinary share equals or exceeds $18.00:

Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a

30-trading

day period ending three business days before sending the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like).

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

If and when the Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the

30-day

redemption period.

Redemption of warrants when the price per share of Class

A ordinary shares equals or exceeds $10.00:

Once the warrants become exercisable, the Company may redeem the outstanding warrants:

•

in whole and not in part;

•

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of shares of Class A ordinary shares;

•

if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share

sub-divisions,

share dividends, reorganizations, recapitalizations and the like); and

•

if the Reference Value is less than $18.00 per share (as adjusted for share

sub-divisions,

share dividends, reorganization, recapitalizations and the like) the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s Board, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares and Alignment Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described above under “Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00” and “Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

As of September 30, 2022 and December 31, 2021, there were 10,533,333 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants included in the Units sold in the IPO, except that (x) the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be

non-redeemable

so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Table of Contents

AUSTERLITZ ACQUISITION CORPORATION I

NOTES TO UNAUDITED CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 9. FAIR VALUE MEASUREMENTS

Warrant Liabilities

The Warrants are accounted for as liabilities pursuant to ASC

815-40

and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants are recorded in the condensed consolidated statements of operations each period.

Public Warrants

and Private Placement Warrants have a fair value of $0 which is included in the unaudited condensed balance sheet as of September 30, 2022. As a result of the plan to liquidate the cash held in the Trust Account to shareholders and dissolve the Company (see note 1) which was initiated by management and the Board prior to the balance sheet date and because the warrants will expire worthless, the Public Warrants and Private Placements were written off as of September 30, 2022.

The following table presents the fair value hierarchy for liabilities measured at fair value on a recurring basis as of December 31, 2021:


	Level 1		Level 2		Level 3		Total
Liabilities:
Public Warrants	$	18,112,500	$	—	$	—	$	18,112,500
Private Placement Warrants		—		11,060,000		—		11,060,000

Total liabilities	$	18,112,500	$	11,060,000	$	—	$	29,172,500

Upon consummation of the IPO on March 2, 2021, the Company’s Warrants were classified as Level 3 due to unobservable inputs used in the initial valuation. On April 23, 2021, the Public Warrants surpassed the

52-day

threshold waiting period to be publicly traded in accordance with the Prospectus filed March 1, 2021. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, the Company classified the Public Warrants as Level 1. The Private Placement Warrants are subject to a call alongside the Public Warrants, it is assumed that the trading price of the public warrants is reflective of the fair value of the Private Placement Warrants. Accordingly, the Company classified the Private Placement Warrants as Level 2.

Initially, the estimated fair value of the warrant liability was determined using Level 3 inputs. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units is classified as Level 1 due to the use of an observable market quote in an active market which began in the quarter ended September 30, 2021. As of December 31, 2021, the closing price of the Public Warrants was used as the fair value for the Private Warrants. As such at December 31, 2021, the Private Placement Warrants were transferred to Level 2 due to a make-whole provision which allows the Company to use the value of the closing price of the Public Warrants.

Gain (loss) on change in fair value of warrant liability on the unaudited condensed consolidated statements of operations for the nine months ended September 30, 2022 and 2021, is $29,172,500 and $(3,677,499), respectively.

NOTE 10. SUBSEQUENT EVENTS

In accordance with ASC Topic 855,

Subsequent Events

, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company evaluated subsequent events that occurred after the balance sheet date up to the date the condensed consolidated financial statements were issued and has concluded that with the exception of the events discussed below, there were no subsequent events that would require adjustment or disclosure in the financial statements.

On October 3, 2022, the Company filed a preliminary proxy statement to redeem the Public Shares through a tender offer and amend its March 2, 2023 expiration date to the chosen date of the shareholder meeting for which proxies are being solicited. Upon approval by the Company’s shareholders of the proposals set forth in the proxy statement, the Company would redeem the Public Shares and begin liquidation proceedings. The Sponsor believes that consummation of a suitable business combination is highly improbable, and it is therefore in shareholders’ best interests to return the cash held in the Trust Account to holders of Public Shares within calendar 2022 rather than wait for expiration in 2023. The Company will be dissolved subsequent to the return of the cash in trust to holders of Public Shares.

On October 6, 2022, the New York Stock Exchange notified the Company that it determined to commence proceedings to delist the Public Warrants and on October 19, 2022 the New York Stock Exchange made the applicable filing to formally delist the Public Warrants.

On October 28, 2022, the Company filed a definitive proxy statement relating to a special meeting of shareholders to approve (i) an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (the “Charter Amendment Proposal”) and (ii), an amendment to its Investment Manager Trust Agreement (the “Trust Amendment Proposal” and together with the Charter Amendment Proposal, the “Proposals”), which would, if implemented, allow the Company to redeem all of its outstanding Public Shares in advance of the Company’s contractual expiration date of March 2, 2023 by changing the date by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, or similar business combination from March 2, 2023 to November 22, 2022 (the “Amended Termination Date”). In connection with the approval of the Charter Amendment Proposal, the holders of Public Shares may elect to redeem all or a portion of their Public Shares in exchange for their pro rata portion of the funds held in the Trust Account (the “Voluntary Redemption”). The Company expects to complete the Voluntary Redemption on or around the Amended Termination Date if shareholders approve the Proposals. If the Proposals are approved, the Company will redeem all remaining Public Shares not redeemed in the Voluntary Redemption not more than ten business days after the Amended Termination Date (the “Mandatory Redemption”). The Company expects to complete the Mandatory Redemption on or around December 2, 2022, if shareholders approve the Proposals. Additionally, the last day of trading of the Public Shares will be November 22, 2022, if shareholders approve the Proposals.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Austerlitz Acquisition Corporation I, formerly known as Foley Trasimene Acquisition Corporation III. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to Austerlitz Acquisition Sponsor, LP I. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (our “Annual Report”) and in any of the Company’s subsequent SEC filings. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

The following discussion should be read in conjunction with our Annual Report.

Overview

We are a blank check company incorporated on December 21, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses. We intend to effectuate a Business Combination using cash from the proceeds of our IPO and the Private Placement, the proceeds of the sale of our shares in connection with a Business Combination, shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.

The registration statement for our Initial Public Offering was declared effective on February 25, 2021. On March 2, 2021, we completed our IPO of 69,000,000 Units sold to the public, including the issuance of 9,000,000 Units as a result of the underwriters’ exercise in full of its over-allotment option, at the price of $10.00 per Unit, generating gross proceeds of $690,000,000. Each Unit consists of one Class A ordinary share of the Company and one-fourth of one redeemable warrant. Each whole Public Warrant entitles the holder to purchase one of our Class A ordinary shares at an exercise price of $11.50 per share, subject to adjustment. Simultaneously with the closing of our IPO, we completed the sale to the Sponsor of an aggregate of 10,533,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, generating gross proceeds of approximately $15,800,000. Each Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The proceeds from the Private Placement Warrants were added to the net proceeds from the IPO held in the Trust Account.

Following our IPO, the full exercise of the over-allotment option and the sale of the Private Placement Warrants, a total of $690,000,000 was placed in the Trust Account. We incurred $38,680,632 in transaction costs, including $13,800,000 of underwriting fees, $24,150,000 of deferred underwriting fees and $730,632 of other offering costs. Offering costs of $1,623,874 were allocated to warrant liabilities and expensed as incurred.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of its IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial business combination must be with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with an initial business combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act.

On October 3, 2022, the Company filed a preliminary proxy statement to redeem the Public Shares through a tender offer and amend its March 2, 2023 expiration date to the chosen date of the shareholder meeting for which proxies are being solicited. Upon approval by the Company’s shareholders of the proposals set forth in the proxy statement, the Company would redeem the Public Shares and begin liquidation proceedings. The Sponsors believe that consummation of a suitable business combination is highly improbable, and it is therefore in shareholders’ best interests to return the cash held in the Trust Account to shareholders within calendar year 2022 rather than wait for expiration in 2023. The Company will be dissolved subsequent to the return of the cash in trust to our shareholders. On October 28, 2022, the Company filed the related definitive proxy statement. See Note 10 to our condensed consolidated financial statements included in Item 1 of Part I of this Quarterly Report for further discussion.

The COVID-19 pandemic has caused difficult market and economic conditions globally since its outbreak in 2020 and the full impact of COVID-19 continues to evolve. The impact of the COVID-19 pandemic on our results of operations, financial position and cash flows will depend on future developments, including resurgences and variants of the virus that causes COVID-19, as well as efforts to reduce its spread, such as travel bans and other restrictions. These developments and the impact of the COVID-19 pandemic on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy continue to be impacted for an extended period, our ability to complete our initial Business Combination may be materially adversely affected due to significant governmental measures to contain the COVID-19 pandemic or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit our ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate our initial Business Combination in a timely manner.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for our IPO and, after completing our IPO, identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after completion of a Business Combination. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses as we conduct due diligence on prospective Business Combination candidates. Additionally, we recognize non-cash gains and losses with other income (expense) related to changes in recurring fair value measurement of our Warrant liabilities at each reporting period.

For the nine months ended September 30, 2022, we had net income of $28,394,781, which consists of $777,719 in general and administrative expenses which were more than offset by non-cash loss of $29,172,500 related to changes in fair value of the derivative warrant liabilities. For the nine months ended September 30, 2021, we had a net loss of $9,599,566 which consisted of $3,079,072 in general and administrative expenses, $3,677,499 related to changes in fair value of the derivative warrant liabilities, $2,212,251 related to the loss on the change in fair value of backstop liability, $3,450,000 related to backstop placement fee expense and $1,605,246 related to transaction costs allocated to derivative warrant liabilities.

For the three months ended September 30, 2022, we had net income of $7,378,609, which consists of $256,251 in general and administrative expenses, more than offset by non-cash gain of $7,634,860 related to changes in the fair value of the derivative warrant liabilities. For the three months ended September 30, 2021, we had net income of $4,035,669 which consisted of $2,326,673 in general and administrative expenses, more than offset by $1,111,334 related to the gain on the change in the fair value of the derivative warrant liabilities and $5,251,008 related to the gain on the change in fair value of backstop liability.

Liquidity and Capital Resources

As of September 30, 2022, we had cash of $1,502,331 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to fund working capital and pay third-party service providers for services rendered to the Company.

As of September 30, 2022, we had cash of $690,000,000 held in the Trust Account. We intend to redeem our outstanding Class A ordinary shares (the “Public Shares”) for cash held in the Trust Account prior to December 31, 2022. The Company expires by its terms on March 2, 2023, however, the Company has filed a preliminary proxy statement to amend the March 2, 2023 expiration date to the date of the shareholders meeting for which proxies are being solicited. The Sponsors believe that consummation of a suitable merger is highly improbable, and it is therefore in shareholders’ best interests to return the cash held in the Trust Account within calendar year 2022 rather than wait for expiration in 2023.

For the nine months ended September 30, 2022, cash used in operating activities was $2,465,846 and is primarily attributable to payment of expenses during the period.

For the nine months ended September 30, 2021, cash used in operating activities was $1,044,743 which was primarily attributable to payments of expenses in the period.

The Company had no cash flow from investing or financing activities in the nine months ended September 30, 2022.

For the nine months ended September 30, 2021, net cash used in investing activities was $690,000,000, which consisted of $690,000,000 investment of cash into the Trust Account. Net cash provided by financing activities of $691,221,205 was affected by $191,827 of repayment of promissory note – related party, and offset by $166,827 advances from related party, $675,446,205 of proceeds from sale of Units, net of deferred underwriting fees paid, and $15,800,000 of proceeds from the sale of Private Placement Warrants.

See discussion under the header “Liquidity and Going Concern Consideration” in Note 1 and in Note 10 to our condensed consolidated financial statements included in Item 1 of Part I of this Quarterly Report for discussion of the Company’s plan to return the cash held in the Trust Account to shareholders and management’s consideration of the Company’s ability to continue as a going concern.

Off-Balance Sheet Financing Arrangements

We had no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2022 or December 31, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities.

We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay Cannae a monthly fee up to $5,000 for office space and administrative support services. We began incurring these fees on February 25, 2021 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and our liquidation.

Critical Accounting Estimates

The preparation of condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and expenses during the period reported. Actual results could materially differ from those estimates. We have identified the following critical accounting estimates effecting our financial statements:

Warrant Liabilities

The Company accounts for the Warrants as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the Warrant Agreement and the applicable authoritative guidance in ASC 480 and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the Warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815, including whether the Warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance of the Warrants and as of each subsequent quarterly period end date while the Warrants are outstanding. For issued or modified instruments such as warrants and forward purchases of equity that meet all of the criteria for equity classification, such instruments are required to be recorded as a component of additional paid- in capital at the time of issuance. For issued or modified instruments that do not meet all the criteria for equity classification, such instruments are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of liability-classified instruments are recognized as a non-cash gain or loss on the condensed consolidated statements of operations.

The Company accounts for the Warrants in accordance with ASC 815-40 under which the Warrants do not meet the criteria for equity classification and must be recorded as assets or liabilities.

See Note 8 to our unaudited condensed consolidated financial statements included in Item 1 of Part I of this Quarterly Report for further discussion of the pertinent terms of the Warrants and Note 9 for further discussion of the methodology used to determine the fair value of the Company’s liability for the Warrants.

Class A Ordinary Shares Subject to Possible Redemption

We account for our Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of our unaudited condensed consolidated balance sheets.

Net Income (Loss) per Ordinary Share

The Company has three classes of shares, one for each of its Class A, Class B, and Class C ordinary shares. Income and losses are shared pro rata between the three classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the year. Refer to Note 2 to our unaudited condensed consolidated financial statements included in Item 1 of Part I of this Quarterly Report for further discussion of the calculation of our net income (loss) per share.

Recently Issued Accounting Pronouncements

Refer to Note 2 to our unaudited condensed consolidated financial statements included in Item 1 of Part I of this Quarterly Report for discussion of management’s consideration of recently issued accounting pronouncements.

ITEM 4.

CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management was required to apply its judgment in evaluating and implementing possible controls and procedures.

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective, due to the material weakness in our internal control over financial reporting related to the Company’s accounting for complex financial instruments as described in the Explanatory Note in our Quarterly Report Form 10-Q/A filed on January 10, 2022 and in the footnotes to the financial statements included in our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021, as filed with the SEC on May 17, 2021. As a result, we performed additional analyses as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Management believes that the financial statements included in this Quarterly Report present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

Other than the steps taken to remediate the material weakness identified in prior periods and further described below, there was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

We have previously identified a material weakness in our internal control over financial reporting. The material weakness was due to management’s review of the accounting treatment for the financial instruments issued in the initial public offering and sold in the concurrent private placement. Management’s review was insufficient to identify a classification error that led to our restatement of our financial statements, as described in Note 2 to our Quarterly Report Form 10-Q/A filed on January 10, 2022. Management has made changes in its internal control over financial reporting to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements, including enhanced communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. Given the Company’s plan to return the cash held in the Trust Account to holders of Public Shares and subsequently liquidate, we do not expect that we will ultimately validate that those processes and controls are operating effectively. The Company can offer no assurance that these changes will ultimately have the intended effects. As of the date of this Quarterly Report, the material weakness has not been remediated.

PART II – OTHER INFORMATION

ITEM 1A.

RISK FACTORS.

There have been no material changes to our risk factors as disclosed in “Risk Factors” included in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2021.

ITEM 6.

EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.


No.		Description of Exhibit

31.1*		Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

32.2**		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Filed herewith.

**	Furnished.

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	AUSTERLITZ ACQUISITION CORPORATION I

Date: November 8, 2022		/s/ David W. Ducommun
	Name:	David W. Ducommun
	Title:	President
		(Principal Executive Officer)

Date: November 8, 2022		/s/ Bryan Coy
	Name:	Bryan Coy
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

Large Accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

Austerlitz Acquisition Corp I 10-Q